Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Paul Hartmann AG has 2 pending office actions currently active. These actions are assigned to 2 distinct examiners, meaning each pending matter is under a different review. YOO, REGINA M is the busiest examiner for the company, with 1 pending office action.
This distribution shows that the company's current patent prosecution is split between two separate examiners, requiring coordination across different individual perspectives at the patent office. This lack of concentration means there is no single primary examiner for the company's active matters. Practitioners must manage two independent prosecution tracks for these pending applications.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §112 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YOO, REGINA M | 1 | 63.8% | +6.1% |
| WITHERSPOON, SIKARL A | 1 | 86.2% | -20.1% |
| FUBARA, BLESSING M | 1 | 62.2% | +34.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18580551 | IRRADIATION CROSSLINKING AND STERILIZATION OF SILICONE | WITHERSPOON, SIKARL A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18269233 | HYDROGEL FOR TREATING PRESSURE ULCERS | FUBARA, BLESSING M | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18722249 | IN-LINE RADIATION STERILIZATION FOR WOUND DRESSINGS | YOO, REGINA M | — | §112 | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18580551 | IRRADIATION CROSSLINKING AND STERILIZATION OF SILICONE | WITHERSPOON, SIKARL A | — | §101§103§112 | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18269233 | HYDROGEL FOR TREATING PRESSURE ULCERS | FUBARA, BLESSING M | 1613 | §102§103DP | Final Rejection | — | Pending | Jun 22, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial